(Q33788426)

29 July 2017

1 reference

title

Therapeutic approach to the patient with irritable bowel syndrome (English)

1 reference

29 July 2017

1 reference

irritable bowel syndrome

1 reference

Camilleri M

1

1 reference

PubMed ID

10588170

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Medicine

29 July 2017

1 reference

29 July 2017

107

1 reference

29 July 2017

5A

1 reference

29 July 2017

27S-32S

1 reference

Controlled treatment trials in the irritable bowel syndrome: a critique.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Irritable bowel syndrome: a technical review for practice guideline development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

The irritable bowel syndrome: mechanisms and a practical approach to management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Review article: irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Gastric wall tension determines perception of gastric distention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Bran supplementation in the treatment of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Bran and irritable bowel syndrome: time for reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

The role of intestinal gas in functional abdominal pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

The Use of Dietary Fiber in the Management of Simple, Childhood, Idiopathic, Recurrent, Abdominal Pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Colonic tone and motility in patients with irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Role of loperamide and placebo in management of irritable bowel syndrome (IBS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

The Effect of Loperamide on Anorectal Function in Normal Healthy Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Loperamide improves anal sphincter function and continence after restorative proctocolectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Idiopathic bile acid catharsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

inferred from DOI database lookup

7 January 2021

based on heuristic

75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Antidepressants for functional gastrointestinal syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Irritable colon and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Psychological significance of the irritable colon syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

American Gastroenterological Association medical position statement: irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

The effect of trimipramine in patients with the irritable bowel syndrome. A double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Effects of desipramine on irritable bowel syndrome compared with atropine and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Comparison of various treatments for irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

Comparison of diet composition in women with and without functional bowel disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

inferred from DOI database lookup

7 January 2021

based on heuristic

A controlled trial of psychological treatment for the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900279-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00279-X

1 reference

29 July 2017

1 reference

PubMed ID

10588170